Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

VGI Partners 2024 Q2 Investor Letter | Buyside Digest

Back to Fund Profile (VGI Partners)

Primary Source Intelligence • Q2 2024 Letter Analysis

VGI Partners Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, VGI Partners. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Digest Analysis

Quick Take

"Amazon, and healthcare spinoff GE Healthcare. The manager demonstrated patience as 2022 detractors recovered while trimming winners and covering unsuccessful shorts."

Executive Summary

VGI Partners delivered a strong 19.7% net return in the first half of 2023 at 72% average net exposure, demonstrating the value of patience as several 2022 detractors became key contributors. The concentrated portfolio focuses on under-appreciated, high-quality businesses across exchanges, technology, and healthcare. Major contributors included Amazon, Spotify, and Qualtrics, while the manager trimmed positions approaching fair value and covered unsuccessful thematic shorts in semiconductors and homebuilding. New positions include GE Healthcare, a spinoff with significant margin expansion potential in medical imaging. The portfolio maintains exposure to financial exchanges like CME Group, Deutsche Börse, and London Stock Exchange Group, benefiting from increased volatility and transformation into data businesses. Despite stretched aggregate market valuations driven by large-cap technology outperformance, the manager continues finding attractive opportunities across sectors. The strategy remains unchanged, targeting 10-15% annual returns through fundamental research and long-term positioning, with the portfolio showing approximately 25% upside to fair value estimates.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

78%

CautiousHigh

High Conviction (78%)

The manager operates a concentrated portfolio with top 10 positions representing 70% of invested capital, names specific holdings with detailed weightings and thesis explanations, and demonstrates willingness to add to positions during weakness while trimming at fair value. The letter provides specific position sizing and clear investment rationales for major holdings.

Growth Outlook

25%

BearishBullish

Bearish (25%)

The manager acknowledges that equity market indices are approaching stretched valuation levels but maintains a constructive view, stating they continue to find attractive opportunities across various sectors and markets. The tone is cautiously optimistic rather than strongly bullish or bearish.

Risk Appetite

40%

DefensiveAggressive

Defensive (40%)

The portfolio maintains 72% average net exposure with a concentrated approach. The manager has been adding new positions while trimming others that approached fair value, and has covered unsuccessful short positions, indicating a selective risk-on tilt.

Capital Deployment

15%

De-riskingDeploying

De-risking (15%)

The manager describes adding new positions including GE Healthcare, London Stock Exchange Group, Rheinmetall and Disney while exiting Mastercard, SAP and Richemont and slightly reducing Amazon and CME Group. This represents portfolio rotation rather than net deployment, with no mention of cash level changes.

Forward Guidance

30%

CautiousExpansionary

Cautious (30%)

The manager expresses optimism about current portfolio positioning and continues to find opportunities, but also maintains hedged language about market conditions and the need for selectivity. The guidance suggests continued deployment but with caution.

Language Signal

20%

BearishBullish

Bearish (20%)

The letter contains balanced language with opportunity-focused terms like 'attractive opportunities,' 'upside potential,' and 'optimistic' balanced against risk language including 'stretched valuations,' 'recession predictions,' and 'economic headwinds.' The net balance is mildly positive.

Perceived Risk

65%

Low RiskElevated

Elevated Risk (65%)

The manager discusses multiple specific risks including yield curve inversion as a recession predictor, student loan payment resumption, stretched market valuations, and provides detailed analysis of economic indicators. Risk discussion is substantial but not alarmist, focusing on identifiable macro factors.

Opportunity Density

60%

ScarceAbundant

Selective (60%)

Despite acknowledging stretched aggregate market valuations, the manager states they are 'continuing to find a number of situations across a variety of sectors and markets where there remain attractive opportunities.' This suggests selective but available opportunities requiring careful screening.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

The strategy explicitly targets 10-15% annual returns 'over the longer term' and emphasizes a 'longer-term investment horizon.' The manager discusses multi-year thesis development for holdings like GE Healthcare and demonstrates patience through holding positions that were detractors in 2022 but recovered in 2023.